2025-06-05
Recently, a research team from Tianjin University published a study in Engineering, designing a novel antifreeze peptide, AVD, by mimicking the "molecular Lego" of Antarctic bacterial antifreeze proteins. Experiments show that frozen cells supplemented with AVD achieved a recovery rate of up to 95.7%, tripling the efficiency of conventional methods.
2025-04-25
New Flexible Auditory Brainstem Implant Offers Hope for Patients with Severe Hearing Loss
A research team from the Swiss Federal Institute of Technology Lausanne (EPFL) recently published a groundbreaking achievement in Nature Biomedical Engineering: the world’s first flexible auditory brainstem implant (ABI). This innovative technology aims to address the side effects caused by the rigid structure of traditional ABIs, offering a more precise and safe hearing restoration solution for patients with severe cochlear nerve damage who cannot benefit from cochlear implants.
2025-04-25
Nature Medicine Review: AI Reconstructs the Paradigm of Drug Development
In the prolonged battle between humanity and disease, drug development remains the decisive battleground. Faced with the harsh reality of an average investment of $2.6 billion, a 15-year timeline, and a success rate below 10%, global scientists are turning to artificial intelligence (AI). This disruptive technology is quietly ushering drug development into a new era of "algorithm-driven" innovation. By 2025, the latest research in Nature journals reveals that generative AI models, exemplified by ChatGPT and Sora, are reshaping the entire drug development pipeline—from target discovery to clinical trials—accelerating "AI-driven drug discovery" from concept to clinical practice.
2025-04-18
Imagine if immune cells in the human body could transform into "smart missiles," relentlessly tracking and destroying cancer cells without harming healthy tissue—this would revolutionize cancer treatment. A groundbreaking announcement from the USC Viterbi School of Engineering reveals the arrival of "EchoBack CAR T cells", a new breed of "thinking" immune warriors propelling targeted cancer therapy into a 2.0 era!
2025-04-17
Gene Scissors 2.0 Unveiled! New Tech Enables "Precision Gene Transplantation"
Nature hailed the breakthrough: "STITCHR fills critical technological gaps and heralds a new era of precision medicine." As clinical trials advance, this molecular revolution—orchestrated by RNA and jumping genes—is set to redefine humanity’s foundational approach to combating disease.
2025-04-11
These advancements demonstrate the feasibility of gene-editing and cloning in resurrecting extinct species, attracting increased funding and scientific collaboration. This progress elevates genetic technology’s potential in biodiversity conservation, biopharmaceuticals, and beyond, heralding a new era of ecological restoration and innovation.
2025-04-11
On April 8 (Tuesday), Xijing Hospital of Air Force Medical University announced a major breakthrough in Asia’s first gene-edited pig kidney transplant for a patient with end-stage renal disease. The patient has maintained stable kidney function for 32 days post-surgery and met discharge standards. This achievement marks a milestone in China’s clinical research on xenotransplantation, offering new hope for patients with terminal kidney disease.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155507
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
